Saturday, July 11, 2026

pharma · Psoriasis · EGFR Positive Non-small Cell Lung Cancer

Betta Pharmaceuticals Co

Betta Pharmaceuticals Co trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.

Hangzhou, CN HQ
23 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Hangzhou, CN
Employees
23
Programs
2
Drugs
4
Patents
0
Intelligence · Clinical Trials

Betta Pharmaceuticals Co clinical trials

Registry index of 2 ClinicalTrials.gov studies linked to Betta Pharmaceuticals Co programs — each row shows trial ID, program name, phase, status, and indication.

Betta Pharmaceuticals Co trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

2 updates

Latest clinical program signals indexed for Betta Pharmaceuticals Co.

  1. Sequential Icotinib Plus Chemotherapy — Approved

    Clinical update
  2. 1% icotinib hydrochloride cream — Phase 1

    Clinical update

Trial registry

2 studies